COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,837 Articles (22,553 medRxiv, 8,284 bioRxiv)

Most recent first Previous |  Page 1259: Articles 12581-12590  | Next

Age-related susceptibility of ferrets to SARS-CoV-2 infection
Martins, M., Fernandes, M. H. V., Joshi, L. R., Diel, D.
10.1101/2021.08.16.456510 — Posted: 2021-08-16
Comparison of Wild Type DNA Sequence of Spike Protein from SARS-CoV-2 with Optimized Sequence on The Induction of Protective Responses Against SARS-Cov-2 Challenge in Mouse Model
Jiang, S., Wu, S., Zhao, G., He, Y., Bao, L., Liu, J., Qin, C., Hou, J., Ding, Y., Wu, J., Yan, J., Humeau, L., Patella, A., Weiner, D. B., Broderick, K., Wang, B.
10.1101/2021.08.13.456164 — Posted: 2021-08-16
Optimization of Non-Coding Regions Improves Protective Efficacy of an mRNA SARS-CoV-2 Vaccine in Nonhuman Primates
Gebre, M., Rauch, S., Roth, N., Yu, J., Chandrashekar, A., Mercado, N., He, X., Liu, J., McMahan, K., Martinot, A., Giffin, T., Hope, D., Patel, S., Sellers, D., Sanborn, O., Barrett, J., Liu, X., Cole, A., Pessaint, L., Valentin, D., Flinchbaugh, Z., Yalley-Ogunro, J., Muench, J., Brown, R., Cook, A., Teow, E., Andersen, H., Lewis, M. G., Mueller, S., Petsch, B., Barouch, D. H.
10.1101/2021.08.13.456316 — Posted: 2021-08-16
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
Karaba, A. H., Zhu, X., Liang, T., Wang, K. H., Rittenhouse, A. G., Akinde, O., Eby, Y., Blankson, J. N., Teles, A., Alejo, J. L., Cox, A. L., Bailey, J. R., Klein, S. L., Pekosz, A., Garonzik-Wang, J. M., Boyarsky, B. J., Segev, D. L., Tobian, A. A., Werbel, W. A.
10.1101/2021.08.11.21261914 — Posted: 2021-08-14
DECREASED BREADTH OF THE ANTIBODY RESPONSE TO THE SPIKE PROTEIN OF SARS-CoV-2 AFTER VACCINATION
Horndler, L., Delgado, P., Romero-Pinedo, S., Quesada, M., Balabanov, I., Laguna-Goya, R., Almendro-Vazquez, P., Llamas, M. A., Fresno, M., Paz-Artal, E., van Santen, H. M., Alvarez, S., Olmo, A., Alarcon, B.
10.1101/2021.08.12.21261952 — Posted: 2021-08-14
The impact of seasonal factors on the COVID-19 pandemic waves
Nesteruk, I., Rodionov, O., Nikitin, A.
10.1101/2021.08.06.21261665 — Posted: 2021-08-14
Beneficial Effects of novel Aureobasidium Pullulans strains produced Beta-1,3-1,6 Glucans on Interleukin-6 and D-Dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study
Raghavan, K., Dedeepiya, V. D., Suryaprakash, V., Rao, K.-S., Ikewaki, N., Sonoda, T., Levy, G. A., Iwasaki, M., Senthilkumar, R., Preethy, S., Abraham, S. J.
10.1101/2021.08.09.21261738 — Posted: 2021-08-14
Screening of cell-virus, cell-cell, gene-gene interactions among kingdoms of life at single cell resolution
Chen, D., Ou, Z., Zhu, J., Ding, P., Wang, H., Luo, L., Ding, X., Lan, T., Wu, W., Yuan, Y., Wu, W., Qiu, J., Zhu, Y., Jia, Y., Wei, Y., Qin, Q., Li, R., Sun, C., Zhao, W., Lv, Z., Pu, M., Yang, S., Chang, A., Wei, X., Chen, F., Yang, T., Wei, Z., Yang, F., Li, Y., Hua, Y., Liu, H.
10.1101/2021.08.13.456190 — Posted: 2021-08-13
A diabetic milieu increases cellular susceptibility to SARS-CoV-2 infections in engineered human kidney organoids and diabetic patients
Garreta, E., Prado, P., Stanifer, M. L., Monteil, V., Hurtado del Pozo, C., Ullate-Agote, A., Vilas-Zornoza, A., Romero, J. P., Jonsson, G., Oria, R., Leopoldi, A., Hagelkrueys, A., Moya-Rull, D., Gonzalez, F., Marco, A., Tarantino, C., Domingo-Pedrol, P., HasanAli, O., Ventura-Aguiar, P., Campistol, J. M., Prosper, F., Mirazimi, A., Boulant, S., Penninger, J., Montserrat, N.
10.1101/2021.08.13.456228 — Posted: 2021-08-13
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Liu, Y., Liu, J., Johnson, B. A., Xia, H., Ku, Z., Schindewolf, C., Widen, S. G., An, Z., Weaver, S., Menachery, V. D., Xie, X., Shi, P.-Y.
10.1101/2021.08.12.456173 — Posted: 2021-08-13 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).